dpp4 vs glp 1 GLP-1 Series Part 1: Utilization drives decline in DPP-4 inhibitors, increase in SGLT2s among competitive drug classes SGLT-2 inhibitors, GLP-1 receptor agonists,

Things like piles of vegetables, popcorn, fibrous foods, anything that took up space without a lot of calories. With appetite naturally lower on GLP-1s, that approach stops working

Results with Zepbound often begin with reduced appetite and improved portion control within the first few weeks as the medication starts working to regulate hunger signals

"That broader availability though still limited may be what's driving GLP-1 usage higher overall." Related: Goldman Sachs doubles down on Novo stock target after key event This story was originally published by TheStreet on Jul 8, 2026, where it first appeared in the Health section

doi: 10.1016/s0014-2999(98)00898-x 125 KimW